What is the share price of JHS Svendgaard Laboratories Ltd (JHS) today?
The share price of JHS as on 10th July 2025 is ₹12.73. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on JHS Svendgaard Laboratories Ltd (JHS) share?
The past returns of JHS Svendgaard Laboratories Ltd (JHS) share are- Past 1 week: -4.18%
- Past 1 month: -2.06%
- Past 3 months: -13.93%
- Past 6 months: -36.60%
- Past 1 year: -40.23%
- Past 3 years: -39.14%
- Past 5 years: -13.78%
What are the peers or stocks similar to JHS Svendgaard Laboratories Ltd (JHS)?
The peers or stocks similar to JHS Svendgaard Laboratories Ltd (JHS) include:What is the market cap of JHS Svendgaard Laboratories Ltd (JHS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of JHS Svendgaard Laboratories Ltd (JHS) is ₹108.97 Cr as of 10th July 2025.What is the 52 week high and low of JHS Svendgaard Laboratories Ltd (JHS) share?
The 52-week high of JHS Svendgaard Laboratories Ltd (JHS) is ₹32.69 and the 52-week low is ₹11.What is the PE and PB ratio of JHS Svendgaard Laboratories Ltd (JHS) stock?
The P/E (price-to-earnings) ratio of JHS Svendgaard Laboratories Ltd (JHS) is -5.51. The P/B (price-to-book) ratio is 0.64.Which sector does JHS Svendgaard Laboratories Ltd (JHS) belong to?
JHS Svendgaard Laboratories Ltd (JHS) belongs to the Consumer Staples sector & FMCG - Personal Products sub-sector.How to buy JHS Svendgaard Laboratories Ltd (JHS) shares?
You can directly buy JHS Svendgaard Laboratories Ltd (JHS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
JHS Svendgaard Laboratories Ltd
JHS Share Price
12.730.78% (-0.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JHS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JHS Performance & Key Metrics
JHS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -5.52 | 0.64 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.35 | 9.55 | 1.63% |
JHS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
JHS Company Profile
JHS Svendgaard Laboratories Limited offers oral care products (toothbrushes, toothpastes, mouthwash, whitening gels and denture products) for national and global FMCG brands.
GODREJCP
PE Ratio
71.07
71.07
1Y Return
10.90%
10.90%
Buy Reco %
82.86
82.86
MARICO
PE Ratio
57.76
57.76
1Y Return
12.51%
12.51%
Buy Reco %
77.78
77.78
DABUR
PE Ratio
52.42
52.42
1Y Return
17.30%
17.30%
Buy Reco %
44.44
44.44
PE Ratio
45.65
45.65
1Y Return
20.69%
20.69%
Buy Reco %
48.15
48.15
PE Ratio
63.47
63.47
1Y Return
21.33%
21.33%
Buy Reco %
50.00
50.00
JHS Forecast
JHS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
JHS
JHS
Income
Balance Sheet
Cash Flow
Annual Normal View
JHS Income Statement
JHS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 105.49 | 172.54 | 130.65 | 152.95 | 108.31 | 95.64 | 96.13 | 75.11 | 94.87 | 94.87 | ||||||||||
Raw Materials | 35.82 | 49.85 | 61.28 | 73.03 | 44.05 | 36.34 | 33.98 | 24.83 | 98.87 | 98.86 | ||||||||||
| Power & Fuel Cost | 3.45 | 3.42 | 3.26 | 3.30 | 2.98 | 2.91 | 2.90 | 2.73 | ||||||||||||
| Employee Cost | 8.66 | 12.10 | 13.52 | 13.44 | 10.08 | 11.45 | 10.19 | 9.21 | ||||||||||||
| Selling & Administrative Expenses | 7.22 | 9.55 | 10.26 | 12.02 | 4.53 | 4.68 | 9.12 | 4.38 | ||||||||||||
| Operating & Other expenses | 38.22 | 51.65 | 36.26 | 46.29 | 37.21 | 31.71 | 56.33 | 30.59 | ||||||||||||
EBITDA | 12.12 | 45.97 | 6.07 | 4.87 | 9.46 | 8.55 | -16.39 | 3.37 | -4.00 | -3.99 | ||||||||||
| Depreciation/Amortization | 6.36 | 6.81 | 7.09 | 8.76 | 7.25 | 7.05 | 6.02 | 6.35 | 7.95 | 7.94 | ||||||||||
| PBIT | 5.76 | 39.16 | -1.02 | -3.89 | 2.21 | 1.50 | -22.41 | -2.98 | -11.95 | -11.93 | ||||||||||
| Interest & Other Items | 0.62 | 0.74 | 1.03 | 1.95 | 1.24 | 1.39 | 0.55 | 0.46 | 0.57 | 0.57 | ||||||||||
| PBT | 5.14 | 38.42 | -2.05 | -5.84 | 0.97 | 0.11 | -22.96 | -3.44 | -12.52 | -12.50 | ||||||||||
| Taxes & Other Items | -16.80 | 12.28 | -1.37 | -3.87 | -0.24 | 4.16 | -27.00 | -18.89 | 7.24 | 7.23 | ||||||||||
| Net Income | 21.94 | 26.14 | -0.68 | -1.97 | 1.21 | -4.05 | 4.04 | 15.45 | -19.76 | -19.73 | ||||||||||
| EPS | 5.30 | 4.91 | -0.11 | -0.32 | 0.19 | -0.62 | 0.56 | 1.96 | -2.37 | -2.52 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
JHS Company Updates
JHS Stock Peers
JHS Past Performance & Peer Comparison
JHS Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesFMCG - Personal Products
Compare valuation-basic on Screener
Consumer StaplesFMCG - Personal Products
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| JHS Svendgaard Laboratories Ltd | -5.51 | 0.64 | — |
| Godrej Consumer Products Ltd | 71.07 | 10.45 | 1.55% |
| Marico Ltd | 57.76 | 22.57 | 1.44% |
| Dabur India Ltd | 52.42 | 8.99 | 1.53% |
JHS Stock Price Comparison
Compare JHS with any stock or ETFCompare JHS with any stock or ETF
JHS
JHS Holdings
JHS Shareholdings
JHS Promoter Holdings Trend
JHS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JHS Institutional Holdings Trend
JHS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
JHS Shareholding Pattern
JHS Shareholding Pattern
JHS Shareholding History
JHS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing JHS stock
smallcases containing JHS stock
Looks like this stock is not in any smallcase yet.
JHS Events
JHS Events
JHS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JHS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JHS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JHS has not given any dividends in last 5 years
JHS Dividends
JHS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeJHS Stock News & Opinions
JHS Stock News & Opinions
Articles & Videos
Earnings
JHS Svendgaard Laboratories reports consolidated net loss of Rs 6.96 crore in the March 2025 quarter
Net Loss of JHS Svendgaard Laboratories reported to Rs 6.96 crore in the quarter ended March 2025 as against net loss of Rs 0.75 crore during the previous quarter ended March 2024. Sales rose 16.20% to Rs 25.17 crore in the quarter ended March 2025 as against Rs 21.66 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 19.74 crore in the year ended March 2025 as against net loss of Rs 4.06 crore during the previous year ended March 2024. Sales rose 29.94% to Rs 92.00 crore in the year ended March 2025 as against Rs 70.80 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales25.1721.66 16 92.0070.80 30 OPM %-21.333.88 --4.36-1.31 - PBDT-4.172.08 PL -1.702.92 PL PBT-6.190.18 PL -9.65-3.43 -181 NP-6.96-0.75 -828 -19.74-4.06 -386 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories revises board meeting date
JHS Svendgaard Laboratories has revised the meeting of the Board of Directors which was scheduled to be held on 17 May 2025. The meeting will now be held on 27 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories to convene board meeting
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
JHS Svendgaard Laboratories reports consolidated net loss of Rs 1.84 crore in the December 2024 quarter
Net loss of JHS Svendgaard Laboratories reported to Rs 1.84 crore in the quarter ended December 2024 as against net profit of Rs 0.01 crore during the previous quarter ended December 2023. Sales rose 58.46% to Rs 22.66 crore in the quarter ended December 2024 as against Rs 14.30 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales22.6614.30 58 OPM %1.10-0.42 - PBDT0.392.17 -82 PBT-1.580.55 PL NP-1.840.01 PL Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories to declare Quarterly Results
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
JHS Svendgaard Laboratories reports consolidated net loss of Rs 10.32 crore in the September 2024 quarter
Net Loss of JHS Svendgaard Laboratories reported to Rs 10.32 crore in the quarter ended September 2024 as against net loss of Rs 0.73 crore during the previous quarter ended September 2023. Sales rose 3.96% to Rs 19.68 crore in the quarter ended September 2024 as against Rs 18.93 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales19.6818.93 4 OPM %-4.322.11 - PBDT-0.090.51 PL PBT-2.07-0.99 -109 NP-10.32-0.73 -1314 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories declare Quarterly Result
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories schedules AGM
JHS Svendgaard Laboratories announced that the 20th Annual General Meeting (AGM) of the company will be held on 10 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
JHS Svendgaard Laboratories reports consolidated net loss of Rs 0.63 crore in the June 2024 quarter
Net Loss of JHS Svendgaard Laboratories reported to Rs 0.63 crore in the quarter ended June 2024 as against net loss of Rs 2.59 crore during the previous quarter ended June 2023. Sales rose 53.96% to Rs 24.48 crore in the quarter ended June 2024 as against Rs 15.90 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.4815.90 54 OPM %8.05-13.40 - PBDT2.17-1.84 LP PBT0.20-3.16 LP NP-0.63-2.59 76 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
JHS Svendgaard Laboratories to declare Quarterly Result
JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -9.11%, vs industry avg of 7.22%
Over the last 5 years, market share decreased from 0.37% to 0.18%